---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-291253"
form_type: "8-K"
ticker: "OSUR"
cik: "0001116463"
company_name: "ORASURE TECHNOLOGIES INC"
filed_at: "2022-11-22T23:59:59+00:00"
generated_at: "2026-06-21T13:50:53.273545+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# OraSure awarded DLA contract for up to 36M InteliSwab COVID-19 tests; pricing below prior federal contract

## Summary
- Contract from US Defense Logistics Agency for InteliSwab COVID-19 Rapid Test; runs Nov 2022 to Nov 2023.
- Estimated 18M tests; maximum award 36M; guaranteed minimum 3.6M tests.
- Pricing under this contract is below previously awarded federal contract.
- Company not updating Q4 2022 guidance due to lack of order timing visibility.

## SEC filing metadata
- accession: 0001193125-22-291253
- form_type: 8-K
- ticker: OSUR
- cik: 0001116463
- company_name: ORASURE TECHNOLOGIES INC
- filed_at: 2022-11-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1116463/000119312522291253/0001193125-22-291253-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1116463/000119312522291253/d415121d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-291253
- JSON: https://secwatch.observer/filing/0001193125-22-291253.json
- Plain text: https://secwatch.observer/filing/0001193125-22-291253.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.